A detailed history of Grey Fox Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Grey Fox Wealth Advisors, LLC holds 1,818 shares of NVS stock, worth $200,998. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,818
Holding current value
$200,998
% of portfolio
0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$106.13 - $120.89 $192,944 - $219,778
1,818 New
1,818 $209 Million
Q4 2023

Jan 17, 2024

SELL
$92.27 - $101.54 $5,536 - $6,092
-60 Reduced 2.47%
2,374 $240 Million
Q2 2023

Aug 03, 2023

SELL
$92.52 - $104.91 $47,185 - $53,504
-510 Reduced 17.32%
2,434 $246 Million
Q1 2023

May 09, 2023

SELL
$80.03 - $92.81 $1,600 - $1,856
-20 Reduced 0.67%
2,944 $271 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $223,930 - $274,229
2,964 New
2,964 $269 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Grey Fox Wealth Advisors, LLC Portfolio

Follow Grey Fox Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Fox Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Fox Wealth Advisors, LLC with notifications on news.